Comparing micro-ultrasound and MRI for prostate cancer screening
Official title: A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen)
Run by University of Alberta · NCT06626022 · Data updated 2026-11-12
This study tests whether high-resolution micro-ultrasound works better than MRI for screening prostate cancer in men aged 50 to 70.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 50 Years to 70 Years |
| Sex | Men only |
| Enrollment | 1284 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 9 sites (Los Angeles, California and 8 other locations) |
| Status | Recruiting |
| Started | May 8, 2025 |
| Main results expected | November 30, 2029 |
| Study ends | November 30, 2029 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT06626022 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are men aged 50 to 70 with a PSA level between 3 and 20 and/or abnormal digital rectal exam results who have never had a prostate biopsy.
✕Probably not a fit
Patients with a prior history of prostate cancer or those who have undergone prostate imaging using micro-ultrasound or MRI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of high-resolution micro-ultrasound compared to multiparametric magnetic resonance imaging (MRI) for screening prostate cancer. Participants will be randomly assigned to receive either imaging modality to determine which is more effective in guiding decisions about prostate biopsies. The study focuses on men aged 50 to 70 with specific prostate health indicators, ensuring a targeted approach to screening. By comparing these two imaging techniques, the study seeks to improve prostate cancer detection methods.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and less invasive screening methods for prostate cancer.
How similar studies have gone: Other studies have explored imaging modalities for prostate cancer, but this specific comparison of micro-ultrasound and MRI is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male sex; 2. Age 50-70; 3. PSA 3-20 and/or abnormal DRE; 4. Biopsy naïve. Exclusion Criteria: 1. Prior personal history of prostate cancer; 2. Prior prostate imaging using microUS or MRI; 3. Contraindication to microUS or MRI; 4. Testosterone replacement therapy within last 12 months; or 5. Androgen deprivation therapy within last 12 months.
Where it's running
-
University of California, Los Angeles (UCLA)
Los Angeles, California, United States Recruiting -
University of British Columbia
Vancouver, British Columbia, Canada Recruiting -
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada Recruiting -
CH de Martigues
Martigues, France Recruiting -
Vestfold Hospital Trust
Tønsberg, Norway Recruiting -
Urologia Clinica Bilbao
Bilbao, Spain Recruiting
Show 3 more locations
-
UT Southwestern Medical Center
Dallas, Texas, United States Not yet recruiting -
University of Alberta
Edmonton, Alberta, Canada Active not recruiting -
CIUSSS du Nord-de-l'Île-de-Montréal
Montréal, Quebec, Canada Not yet recruiting
Study contacts
- Principal investigator: Adam Kinnaird, MD, PhD — University of Alberta
- Study coordinator: Stacey Broomfield, PhD
- Email: sbroomfi@ualberta.ca
- Phone: +1-780-407-5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PSMA PET/MRI-guided prostate biopsy for men with prior negative biopsies and low PI-RADS
This trial will try whether PSMA PET/MRI-guided targeted biopsies find more clinically significant prostate cancer than standard TRUS transperineal saturation biopsies in men with prior negative biopsies, rising PSA or PHI, and PI-RADS ≤3.
-
Compare standard prostate biopsy needles with a novel needle system
A new biopsy needle system is tested against the standard one to see if it retrieves more tissue for analysis and if the tissue quality helps pathologists better diagnose prostate cancer.
-
Trained vs Untrained: How Endurance Status Affects Lung Blood Flow During Blood Volume Changes
This study tests whether highly trained athletes show different lung blood flow responses when blood return to the heart changes, compared with untrained individuals.
-
Deep Brain Reorienting for PTSD in Veterans
This study tests whether Deep Brain Reorienting can help reduce PTSD symptoms in military veterans compared with usual care.
-
Big Steps: Early Walking and Sedentary-Reduction After Stroke
This trial tests whether a guided stepping program and strategies to cut sitting time can help people 50 and older who recently had a stroke improve daily walking and reduce disability.
-
EHR-guided LDL cholesterol optimization after a heart event
A pharmacist-guided program using electronic health records to help adults in Alberta reach LDL goals after a heart event by adjusting medications and ordering tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.